Search

Displaying results 5291 - 5300 of 8698 in total
  1. Drug

    Girentuximab

    go.drugbank.com/drugs/DB05304
    Investigational

    Girentuximab is a monoclonal chimeric (mouse/human) antibody directed against carbonic anhydrase IX, an antigen expressed in 95% of clear cell renal cell carcinomas (RCC).

  2. Target

    Ribosome-binding protein 1

    go.drugbank.com/bio_entities/BE0003466
    TargetHumans

    Acts as a ribosome receptor and mediates interaction between the ribosome and the endoplasmic reticulum membrane

    Synonyms: Ribosome receptor protein, 180 kDa ribosome receptor homolog
  3. Target

    Natural killer cells antigen CD94

    go.drugbank.com/bio_entities/BE0010559
    TargetHumans

    Immune receptor involved in self-nonself discrimination.

    Synonyms: NK cell receptor, Killer cell lectin-like receptor subfamily D member 1Function: HLA-A specific activating MHC class I receptor activity
  4. Drug

    AEM-28-14

    go.drugbank.com/drugs/DB17643
    Experimental

    [L45909] It is being investigated for lipid disorders such as homozygous familial hypercholesterolemia.[L45914] … AEM-28-14 is an analog of [AEM-28], an apolipoprotein E mimetic peptide, with a 400 percent greater cholesterol-lowering efficacy and a several-fold increase in drug tolerability.

  5. Drug

    Ethyl hydroxybenzoate

    go.drugbank.com/drugs/DB13628
    ApprovedInvestigational

    Synonyms: Ethyl p-hydroxybenzoate, p-OxybenzoesaeureaethylesterCategories: Antifungals for Topical Use, Antifungals for Dermatological Use
  6. Drug

    AK119

    go.drugbank.com/drugs/DB16423
    Investigational

    AK119 is a humanized anti-CD73 monoclonal antibody being investigated in the clinical trial NCT04516564 (A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects).[L28315]

  7. Drug

    Endostatin

    go.drugbank.com/drugs/DB06423
    Investigational

  8. Target

    V-type immunoglobulin domain-containing suppressor of T-cell activation

    go.drugbank.com/bio_entities/BE0010797
    TargetHumans

    Immunoregulatory receptor which inhibits the T-cell response (PubMed:24691993). May promote differentiation of embryonic stem cells, by inhibiting BMP4 signaling (By similarity). … May stimulate MMP14-mediated MMP2 activation (PubMed:20666777)

    Synonyms: Platelet receptor Gi24, V-set immunoregulatory receptor
  9. Drug

    Moxaverine

    go.drugbank.com/drugs/DB12251
    Investigational

    Moxaverine has been investigated for the treatment of Retina, Ocular Physiology, and Regional Blood Flow.

    Categories: Drugs for Functional Gastrointestinal Disorders
  10. Drug

    Avena sativa flowering top

    go.drugbank.com/drugs/DB14253
    Approved

    It is not an approved drug.